Prostate Cancer - Dec 3, 2017 Edition

December 3, 2017     Prostate Cancer     The latest prostate cancer news from News Medical

Process of removing cellular debris can fuel tumor growth in metastatic prostate cancer   The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.       New CSHL method pinpoints which prostate tumors pose fatal threat before surgery   The facts about prostate cancer can be confusing. It's the third most common cancer type among Americans - 161,000 men will be diagnosed this year, the National Cancer Institute estimates. Yet according to the NCI, 98.6% will be alive in 5 years.

Hackensack Meridian Health Bayshore Medical Center now offers MRI/ultrasound fusion biopsy   Hackensack Meridian Health Bayshore Medical Center is proud to announce that it has expanded services to include targeted MRI ultrasound for prostate biopsy.

Protein and Peptide Microarray   Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a large scale. Microarrays find their place in epitope mapping and serodiagnostic applications.       Urban American-Indian, Alaskan Native community more likely to have lower cancer survival rates   Compared with the non-Hispanic white population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK